Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performance

Ultrasound in Obstetrics and Gynecology

Volumn 39, Issue 2, 2012, Pages 181-184

  Evans, M I ^a   Krantz, D A ^b   Hallahan, T W ^b   Sherwin, J ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b PERKINELMER INC   (United States)

Author keywords

credentialing; Down syndrome screening; nuchal translucency; quality control

Indexed keywords

ACCREDITATION; ARTICLE; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HEALTH CARE QUALITY; HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; STANDARD; UNITED STATES;

CREDENTIALING; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; QUALITY ASSURANCE, HEALTH CARE; ULTRASONOGRAPHY, PRENATAL; UNITED STATES;

EID: 84856319426     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.9023     Document Type: Article

References (10)

1. Snijders RJ, Thom EA, Zachary JM, Platt LD, Greene N, Jackson LG, Sabbagha RE, Filkins K, Silver RK, Hogge WA, Ginsberg NA, Beverly S, Morgan P, Blum K, Chilis P, Hill LM, Hecker J, Wapner RJ,. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002; 19: 353-359. (Pubitemid 34592131)
2. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH,. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998; 351: 343-346. (Pubitemid 28352196)
3. Monni G, Zoppi MA, Ibba RM, Floris M,. Results of measurement of nuchal translucency before and after training. Lancet 1997; 350: 1631-1632.
4. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME,; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353: 2001-2011. (Pubitemid 41609093)
5. Evans MI, Pergament E,. Impact of quality of nuchal translucency measurements on detection rates of trisomies 13 and 18. Fetal Diag Ther 2010; 27: 68-71.
6. Evans MI, Krantz DA, Hallahan TW, Sherwin JE,. Undermeasurement of nuchal translucencies: implications for screening. Obstet Gynecol 2010; 116: 815-818.
7. Deming WE,. Out of the Crisis. MIT Press: Cambridge, MA, 1986.
8. Cuckle HS,. Monitoring quality control of nuchal translucency. Clin Lab Med 2010; 30: 593-604.
9. Evans MI, Van Decruyes H, Nicolaides KH,. Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy. Fetal Diag Ther 2007; 22: 401-404. (Pubitemid 350014923)
10. Romero R,. Routine obstetric ultrasound. Ultrasound Obstet Gynecol 1993; 3: 303-307.